ISIN | CH0113817123 |
---|---|
Valor Number | 11381712 |
Bloomberg Global ID | BBG0017T9CY3 |
Fund Name | Bellevue Biotech DT CHF |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland | |
Distributor(s) |
Zürcher Kantonalbank Zürich Phone: +41 44 293 93 93 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 3,270.41 CHF | 26.06.2025 |
---|---|---|
Previous Price * | 3,292.78 CHF | 25.06.2025 |
52 Week High * | 3,918.46 CHF | 16.07.2024 |
52 Week Low * | 3,036.56 CHF | 10.04.2025 |
NAV * | 3,270.41 CHF | 26.06.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 24,428,780 | |
Unit/Share Assets *** | 8,695,720 | |
Trading Information SIX |
YTD Performance | -9.48% |
31.12.2024 - 26.06.2025
31.12.2024 26.06.2025 |
---|---|---|
1 month | -0.79% |
27.05.2025 - 26.06.2025
27.05.2025 26.06.2025 |
3 months | -10.89% |
26.03.2025 - 26.06.2025
26.03.2025 26.06.2025 |
6 months | -9.95% |
27.12.2024 - 26.06.2025
27.12.2024 26.06.2025 |
1 year | -10.28% |
26.06.2024 - 26.06.2025
26.06.2024 26.06.2025 |
2 years | -4.45% |
26.06.2023 - 26.06.2025
26.06.2023 26.06.2025 |
3 years | -8.36% |
27.06.2022 - 26.06.2025
27.06.2022 26.06.2025 |
5 years | -12.86% |
26.06.2020 - 26.06.2025
26.06.2020 26.06.2025 |
Equity Participation Rate in % | 80.92 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 16.6695 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 26.06.2025 |
Vertex Pharmaceuticals Inc | 9.35% | |
---|---|---|
Gilead Sciences Inc | 8.95% | |
Amgen Inc | 8.57% | |
Regeneron Pharmaceuticals Inc | 6.20% | |
AstraZeneca PLC ADR | 5.18% | |
Alnylam Pharmaceuticals Inc | 4.03% | |
argenx SE ADR | 3.43% | |
Biomarin Pharmaceutical Inc | 2.83% | |
BeiGene Ltd ADR | 2.72% | |
Sanofi SA ADR | 2.48% | |
Last data update | 30.04.2025 |
TER | 1.22% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | 10.00% |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |